Amplifon has reached another significant milestone in its proposed €2.3 billion acquisition of GN Hearing , a transaction valued at approximately 70–75% of the Italian company’s market capitalisation . To finance the acquisition, Amplifon signed a €1.35 billion senior loan facility at the end of June, backed by a syndicate of 13 international financial institutions , including Goldman Sachs Bank Europe SE and J.P....
No actionable change for clinical practice; this is a major corporate financing event with no direct implication for audiologists' day-to-day patient care.
If completed, the Amplifon–GN Hearing merger would significantly consolidate the global hearing-care market, potentially reshaping device supply chains, brand availability, and competitive pricing for clinics worldwide.
- 01Amplifon signed a €1.35 billion senior loan facility to part-finance the GN Hearing acquisition.
- 02Total deal value is approximately €2.3 billion.
- 03The deal represents ~70–75% of Amplifon's current market capitalisation, signalling major financial leverage.
- 04GN Hearing is a significant hearing-aid manufacturer, so this would be a vertical integration move for Amplifon.
- 05The acquisition remains proposed; closing conditions and regulatory approvals are likely still pending.
The €1.35 billion loan represents approximately 70–75% of Amplifon's market capitalisation.
press releasepartially supportedThe total proposed acquisition price for GN Hearing is €2.3 billion.
press releasesupported
